Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 15709-15710 [2017-06249]
Download as PDF
Federal Register / Vol. 82, No. 60 / Thursday, March 30, 2017 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
utility: (1) Adjusted risk estimates (e.g.,
odds ratio, relative risk, hazards ratio);
(2) discrimination (e.g., area under the
receiver operating characteristic curve
[AUROC]); and (3) measures of
diagnostic accuracy (e.g., sensitivity,
specificity, positive predictive values,
and negative predictive values).
The predictive utility is defined in
terms of the physiologic measure’s
ability to identify patients who have
severe injury. Defining and
operationalizing what ‘‘severe injury’’
means is challenging for several reasons.
Whether a patient had a serious injury
at the time of field triage cannot be
determined conclusively and we expect
that clinical outcomes (e.g., death or
disability) are affected by out-of-hospital
and in-hospital treatment (i.e., a person
can have a serious injury and recover).
For this reason, we accept several
indicators that a patient was seriously
injured. These include outcomes, such
as death, whether the patient required
treatments and interventions used for
serious injury, or whether the injury is
rated as severe using accepted rating
scales. It is possible the review will
identify additional indicators that a
patient had a severe injury; however the
following list includes those that have
been used in prior research.
Indicators of Serious Injury
I. In-hospital mortality.
II. Resource use/intervention
standards or lists.
a. Published Consensus-Based
Criterion Standard—This list defines
need for trauma center care as any one
of the following 10 specific indicators:
Major surgery, advanced airway, blood
products, admission for spinal cord
injury, thoracotomy, pericardiocentesis,
cesarean delivery, intracranial pressure
monitoring, interventional radiology,
and in-hospital death.
b. Need For Life-Saving
Interventions—Lists used by the U.S.
military that include angioembolization,
blood transfusion, cardiopulmonary
resuscitation, chest tube, intubation,
needle decompression, surgical
cricothyrotomy or thoracotomy,
pericardiocentesis, angiography with
embolization, angiography without and
surgical intervention.
c. Major Surgery—Not including
orthopedic surgery.
d. Ratings of Injury Severity—Injury
Severity Score (ISS) >15, as this is a
commonly used threshold for high risk
patients, but other cut-offs will be
considered if used in included studies.
The ISS score is based on an assessment
that divides the body into nine regions,
classifies the level of injury in each of
the three most severely injured regions
VerDate Sep<11>2014
19:09 Mar 29, 2017
Jkt 241001
15709
on a scale of 1 to 6, squares these values,
and adds them together.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Timing
Centers for Disease Control and
Prevention
Physiological measures upon the
arrival of EMS personnel to the scene of
injury, during treatment in the field, and
during transport (referred to as out-ofhospital or in the field). Studies with
measures taken upon arrival at an
emergency department will be
considered. Details about timing of
measurement will be recorded in data
abstraction if they are reported.
Settings
Include:
I. Studies measuring physiologic
compromise in the field/out of
hospital
II. Studies of initial ED measurement as
indirect evidence only if out of
hospital evidence is not available
and the measure is deemed
clinically relevant
III. Studies conducted in civilian or
military settings
Exclude:
Study Designs
Include:
I. Any study that assesses the predictive
utility of included measures either
individually or that compares two
or more measures. Designs may
include trials and prospective and
retrospective observational studies
a. Systematic reviews
Exclude:
I. Nonsystematic reviews,
commentaries, and letters
II. Descriptions of the properties or
performance of measures that do
not include predictive utility
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–06232 Filed 3–29–17; 8:45 am]
BILLING CODE 4160–90–P
Frm 00025
Draft Current Intelligence Bulletin: The
Occupational Exposure Banding
Process: Guidance for the Evaluation
of Chemical Hazards; Notice of Public
Meeting; Request for Comments
Correction
In notice document 2017–5115,
beginning on page 13809, in the issue of
Wednesday, March 15, 2017, make the
following correction:
On page 13809, in the third column,
in the second line of the DATES
paragraph, ‘‘Tuesday, May 23, 2016’’
should read, ‘‘Tuesday, May 23, 2017.’’
[FR Doc. C1–2017–05115 Filed 3–29–17; 8:45 am]
BILLING CODE 1301–00–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
I. Inpatient, clinic, or emergency
department (ED)
II. Studies conducted in developing
countries with out-of-hospital care
systems that differ from those in the
United States
PO 00000
[CDC–2017–0028, Docket Number NIOSH–
290]
Fmt 4703
Sfmt 4703
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: April 24, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710 B
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Kimberly Lynette Houston,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, DHHS,
6710B Rockledge Drive, Bethesda, Maryland
E:\FR\FM\30MRN1.SGM
30MRN1
15710
Federal Register / Vol. 82, No. 60 / Thursday, March 30, 2017 / Notices
20892, 301.827.4902, kimberly.houston@
nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NICHD Genomic
Clinical Variant Expert Curation Panels (U24)
Review.
Date: April 27, 2017.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Residence Inn, Bethesda,
MD 20892.
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, DHHS,
6710B Rockledge Drive, Bethesda, Maryland
20892, 301–435–6878, wedeenc@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 24, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06249 Filed 3–29–17; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rapid Assessment of Zika
Virus (ZIKV) Complications (R21).
Date: April 26, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
19:09 Mar 29, 2017
Jkt 241001
Dated: March 24, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06248 Filed 3–29–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3E61, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5019, schleefrr@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: April 27, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3G30; National
Institutes of Health/NIAID, 5601 Fishers
Lane, Drive, MSC 9823, Bethesda, MD
20892–9823, 240–669–5058, rathored@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; The Preconception
Exposure Window and Health of the
Offspring.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Date: April 18, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Place Durham-Southpoint;
7840 NC 751 Hwy., Durham, NC 27713.
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30/
Room 3171, Research Triangle Park, NC
27709, (919) 541–0670, worth@niehs.nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Research Careers
(K01,K22,K99/R00) in Environmental Health
Sciences.
Date: April 18, 2017.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Nat. Inst. of Environmental Health
Sciences, Rodbell 101 ABC, 111 T.W.
Alexander Drive, Research Triangle Park, NC
27709, (Telephone Conference Call).
Contact Person: Janice B Allen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Science, P.O. Box 12233, MD EC–30/
Room 3170 B, Research Triangle Park, NC
27709, (919) 541–7556.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Research Careers (K01) in
Environmental Health Sciences.
Date: April 19, 2017.
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Keystone Building, 530 Davis Drive, Research
Triangle Park, NC 27709 (Telephone
Conference Call).
Contact Person: RoseAnne M McGee;
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30;
Research Triangle Park, NC 27709, (919) 541–
0752; mcgee1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: March 24, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06250 Filed 3–29–17; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\30MRN1.SGM
30MRN1
Agencies
[Federal Register Volume 82, Number 60 (Thursday, March 30, 2017)]
[Notices]
[Pages 15709-15710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06249]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: April 24, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6710 B Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kimberly Lynette Houston, Scientific Review
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, DHHS,
6710B Rockledge Drive, Bethesda, Maryland
[[Page 15710]]
20892, 301.827.4902, kimberly.houston@nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; NICHD Genomic Clinical Variant
Expert Curation Panels (U24) Review.
Date: April 27, 2017.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Residence Inn, Bethesda, MD 20892.
Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, DHHS,
6710B Rockledge Drive, Bethesda, Maryland 20892, 301-435-6878,
wedeenc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 24, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06249 Filed 3-29-17; 8:45 am]
BILLING CODE 4140-01-P